|
Xenobiotic-Metabolizing Enzymes
|
Z01 BC 005562
|
$622,528
|
$155,632
|
Gonzalez, Frank
|
CCR (NCI)
|
|
Xenobiotic Receptors
|
Z01 BC 005708
|
$622,528
|
$311,264
|
Gonzalez, Frank
|
CCR (NCI)
|
|
WUMC-Cancer and Leukemia Group B
|
5U10CA077440-11
|
$334,932
|
$83,733
|
BARTLETT, NANCY
|
WASHINGTON UNIVERSITY
|
|
Wound Angiogenesis as a Biomarker for Tumor Angiogenesis
|
5K24CA113755-03
|
$122,601
|
$122,601
|
HURWITZ, HERBERT
|
DUKE UNIVERSITY
|
|
Workshops on Viral Pathogenesis and Oncogenesis
|
5R13CA095919-07
|
$9,000
|
$1,350
|
FAN, HUNG
|
UNIVERSITY OF CALIFORNIA IRVINE
|
|
Women's Health Study: Continued Follow-up
|
5R01CA047988-18
|
$1,680,173
|
$336,035
|
BURING, JULIE
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Wnt signaling in Colon Cancer
|
5R01CA108697-04
|
$276,029
|
$276,029
|
WATERMAN, MARIAN
|
UNIVERSITY OF CALIFORNIA IRVINE
|
|
Wnt Antagonist Gene Hypermethylation in Circulating DNA: Cancer Biomarker
|
Z01 BC 011050
|
$32,786
|
$3,279
|
Rubin, Jeffrey
|
CCR (NCI)
|
|
Whole Genome Scan for Modifier Genes in Colorectal Cancer
|
1R01CA126895-01A2
|
$1,643,478
|
$1,643,478
|
LE MARCHAND, LOIC
|
UNIVERSITY OF HAWAII AT MANOA
|
|
Washington University Small Animal Imaging Resource
|
5U24CA083060-10
|
$633,099
|
$31,655
|
ACKERMAN, JOSEPH
|
WASHINGTON UNIVERSITY
|
|
Vitamin D and Colorectal Cancer
|
1R01CA122299-01A2
|
$360,095
|
$360,095
|
BENYA, RICHARD
|
UNIVERSITY OF ILLINOIS AT CHICAGO
|
|
Virus-host interactions in hepatocarcinogenesis
|
5P01CA123328-02
|
$1,035,536
|
$1,035,536
|
OU, J.-H. James
|
UNIVERSITY OF SOUTHERN CALIFORNIA
|
|
Virginia Mason Community Clinical Oncology Program
|
5U10CA035192-25
|
$453,250
|
$72,520
|
Vuky, Jacqueline
|
BENAROYA RESEARCH INST AT VIRGINIA MASON
|
|
Viral Vaccine Vectors to Prevent Hepatocellular Carcinoma
|
1R01CA131133-01A1
|
$274,730
|
$274,730
|
ROBEK, MICHAEL
|
YALE UNIVERSITY
|
|
Viral and Cellular Determinants of Hepatitis B Virus Pathogenesis
|
5R01CA056533-16
|
$423,021
|
$423,021
|
Schneider, Robert
|
NEW YORK UNIVERSITY SCHOOL OF MEDICINE
|
|
Veterans Administration hospitalization database, Patient Treatment File, and Out
|
Z01 CP010183-00580
|
$179,292
|
$35,858
|
Anderson, William
|
DCEG (NCI)
|
|
VDR Variants, Nutrient Intakes, and Adenoma Recurrence
|
5K07CA106269-04
|
$134,115
|
$134,115
|
JACOBS, ELIZABETH
|
UNIVERSITY OF ARIZONA
|
|
VCU Minority-Based CCOP
|
5U10CA052784-18
|
$577,110
|
$103,880
|
ROBERTS, JOHN
|
VIRGINIA COMMONWEALTH UNIVERSITY
|
|
Variations in Colonoscopy Screening: A Population Based Study
|
1R01CA131141-01A1
|
$661,835
|
$661,835
|
Dietrich, Allen
|
DARTMOUTH COLLEGE
|
|
Variation in NTP use by the HCV polymerase and response to therapy
|
3R21CA125321-02S1
|
$20,868
|
$20,868
|
TAVIS, JOHN
|
SAINT LOUIS UNIVERSITY
|
|
Variation in NTP use by the HCV polymerase and response to therapy
|
5R21CA125321-02
|
$147,000
|
$147,000
|
TAVIS, JOHN
|
SAINT LOUIS UNIVERSITY
|
|
Vanderbilt In Vivo Cellular and Molecular Imaging Center
|
1P50CA128323-01A1
|
$1,500,000
|
$420,000
|
GORE, JOHN
|
VANDERBILT UNIVERSITY
|
|
VALIDATION AND QUANTIFICATION OF FFPE ANTIGEN RETRIEVAL BY PROTEOME ANALYSIS
|
2R42CA122715-03
|
$748,362
|
$374,181
|
SAXENA, SATYA
|
CALIBRANT BIOSYSTEMS, INC.
|
|
Validation and extension of the PREMM Model for mismatch repair gene mutations
|
1R01CA132829-01A1
|
$414,226
|
$414,226
|
SYNGAL, SAPNA
|
DANA-FARBER CANCER INSTITUTE
|
|
Validating Area-Level Behavioral Profiles for Cancer Disparities Research
|
5R21CA124921-02
|
$164,000
|
$41,000
|
Klassen, Ann
|
JOHNS HOPKINS UNIVERSITY
|
|
UWCCC National Cooperative Drug Discovery Group for Can*
|
3U19CA113297-04S1
|
$25,000
|
$12,500
|
SHEN, BEN
|
UNIVERSITY OF WISCONSIN MADISON
|
|
UWCCC National Cooperative Drug Discovery Group for Can*
|
5U19CA113297-04
|
$1,044,616
|
$522,308
|
SHEN, BEN
|
UNIVERSITY OF WISCONSIN MADISON
|
|
UTMB Center for Population Health and Health Disparities
|
3P50CA105631-05S1
|
$212,000
|
$101,760
|
GOODWIN, JAMES
|
UNIVERSITY OF TEXAS MEDICAL BR GALVESTON
|
|
Utilizing Glycosyltransferases for Bioconjugation
|
Z01 BC 010742
|
$245,813
|
$24,581
|
Qasba, Pradman
|
CCR (NCI)
|
|
Using Technology to Enhance Cancer Communication and Improve Clinical Outcomes
|
2P50CA095817-06
|
$1,742,975
|
$557,752
|
GUSTAFSON, DAVID
|
UNIVERSITY OF WISCONSIN MADISON
|
|
Using Targeted Immunotherapy to Enhance Chemotherapy of Colorectal Cancer
|
5R01CA123277-02
|
$311,600
|
$311,600
|
BEDI, ATUL
|
JOHNS HOPKINS UNIVERSITY
|
|
Using NMD to identify Mutated genes in colon cancer
|
5R01CA109256-05
|
$328,360
|
$328,360
|
IONOV, YURIJ
|
ROSWELL PARK CANCER INSTITUTE CORP
|
|
Using mouse knockouts to unravel endothelial gene function
|
Z01 BC 010736
|
$172,500
|
$34,500
|
St. Croix, Brad
|
CCR (NCI)
|
|
Using Mouse Endoscopy for Evaluating Colon Cancer
|
1R01CA125691-01A2
|
$354,513
|
$354,513
|
Rosenberg, Daniel
|
UNIVERSITY OF CONNECTICUT SCH OF MED/DNT
|
|
Using Message Framing to Promote Physical Activity in Colorectal Cancer Survivors
|
1R21CA125458-01A2
|
$210,600
|
$210,600
|
JONES, LEE
|
DUKE UNIVERSITY
|
|
Using Diazeniumdiolate Chemistry to Design Nitric Oxide-Based Therapies
|
Z01 BC 005673
|
$1,225,024
|
$245,005
|
Keefer, Larry
|
CCR (NCI)
|
|
Use of Quantitative RT-PCR for Staging Esophageal Cancer
|
5R01CA090665-08
|
$263,273
|
$263,273
|
LUKETICH, JAMES
|
UNIVERSITY OF PITTSBURGH AT PITTSBURGH
|
|
Use of hyaluronan for treatment of chemotherapy sequelae
|
1R41CA126004-01A1
|
$158,366
|
$158,366
|
KHALDOYANIDI, SOPHIA
|
CASCADE LIFESCIENCES, INC.
|
|
USC Consortium:Colorectal Cancer Family Registry
|
3U01CA074799-09S2
|
$221,749
|
$221,749
|
HAILE, ROBERT
|
UNIVERSITY OF SOUTHERN CALIFORNIA
|
|
USC Center for Transdisciplinary Research on Energetics*
|
3U54CA116848-04S1
|
$62,100
|
$62,100
|
GORAN, MICHAEL
|
UNIVERSITY OF SOUTHERN CALIFORNIA
|
|
USC Center for Transdisciplinary Research on Energetics*
|
5U54CA116848-04
|
$2,254,533
|
$2,254,533
|
GORAN, MICHAEL
|
UNIVERSITY OF SOUTHERN CALIFORNIA
|
|
Urine Biomarker Discovery for Early Detection of Liver Cancer
|
1R01CA125642-01A2
|
$381,911
|
$381,911
|
SU, YING-HSIU
|
DREXEL UNIVERSITY
|
|
UPSTATE CAROLINA COMMUNITY CLINICAL ONCOLOGY PROGRAM
|
5U10CA035119-24
|
$1,880,470
|
$357,289
|
BEARDEN, JAMES
|
SPARTANBURG REGIONAL MEDICAL CENTER
|
|
UPRCCC/MDACC: Partnership for Excellence in Cancer Research
|
2U54CA096297-06A1
|
$1,584,860
|
$15,849
|
FRONTERA-ROURA, WALTER
|
UNIVERSITY OF PUERTO RICO MED SCIENCES
|
|
UPPER GASTROINTESTINAL CANCER GENETICS STUDIES
|
N02RC066211-013
|
|
$0
|
TI, DING
|
Shanxi Cancer Institute & Hospital
|
|
UPMC McKeesport/ROCOG Radiation Oncology Minorities Outreach Group
|
5U56CA105486-06
|
$347,891
|
$86,973
|
HERON, DWIGHT
|
UPMC MC KEESPORT
|
|
University of Maryland Biomarker Reference Laboratory
|
3U24CA115091-04S1
|
$150,000
|
$150,000
|
STASS, STANFORD
|
UNIVERSITY OF MARYLAND BALTIMORE
|
|
University of Maryland Biomarker Reference Laboratory
|
5U24CA115091-04
|
$409,180
|
$409,180
|
STASS, STANFORD
|
UNIVERSITY OF MARYLAND BALTIMORE
|
|
University of Iowa CALGB Institutional Grant
|
5U10CA047642-21
|
$110,413
|
$27,603
|
VAENA, DANIEL
|
UNIVERSITY OF IOWA
|
|
Underutilization of Surgical Resection in Patients with Pancreatic Cancer
|
1K07CA130983-01A1
|
$126,591
|
$126,591
|
RIALL, TAYLOR
|
UNIVERSITY OF TEXAS MEDICAL BR GALVESTON
|
Total relevant funding to Digestive Diseases for this search: $439,873,191
|